New Advances in Disease-Modifying Therapies for Relapsing and Progressive Forms of Multiple Sclerosis

Area of Science:

• Neuroscience
• Immunology
• Neurology

Background:

• Multiple sclerosis (MS) is a chronic autoimmune central nervous system disease.
• Characterized by inflammation, demyelination, and axonal loss from early stages.
• Affects young adults (20-40 years) predominantly females.

Purpose of the Study:

• To review the growing landscape of multiple sclerosis treatments.
• To highlight the increasing interest in novel therapeutic strategies.
• Focus on drugs promoting neuroprotection and myelin repair.

Main Methods:

• Review of current and emerging multiple sclerosis therapies.
• Analysis of drug mechanisms targeting neurodegeneration and remyelination.
• Synthesis of recent advancements in MS treatment research.

Main Results:

• Treatment options for MS have significantly expanded.
• Newer drugs with novel mechanisms of action are available.
• Emerging therapies aim to address neuroprotection and myelin repair.

Conclusions:

• There is a growing interest in developing drugs for MS.
• Novel therapeutic approaches focus on halting neurodegeneration.
• Future treatments aim to promote myelin repair and neuroprotection in MS.